| Application no. and date | 05802290.6 (espacenet) (Federated) (European Patent Register), 20051111 | | Patent/reg. no. and date | DK/EP 1833821, 20110330 | | Publication date | 20070919 | | Priority no. and date | WO PCT/EP2004/012774, 20041111 | | EP pub. no. and date |
EP 1833821 20070919 | | Effective date | | | Applicant/owner | Actelion Pharmaceuticals Ltd., Gewerbestrasse 16
4123 Allschwil, CH | | Applicant ref. no. | P48556DK01 | | Inventor | FISCHLI, Walter, Obertorweg 64
4123 Allschwil, CH,
Bolli, Martin, Bachgrabenweg 21
4123 Allschwil, CH,
Clozel, Martine, Winterhalde 3b
4102 Binningen, CH,
Weller, Thomas, Hoelzlistrasse 58
4102 Binningen, CH,
BOSS, Christoph, Muesmattweg 98
4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 9/00 (2006.01) , C07D 403/12 (2006.01) | | Title | Sulfamider som endotelreceptorantagonister til behandlingen af kardiovaskulære sygdomme | | Int. application no. | IB2005053716 | | Int. publication no. | WO2006051502 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
